NorthWest Biotherapeutics Inc (NWBO)

[alphapuppy]

Iclight

Yes, I agree. I underestimated the effects that pseudoprogression would have on progression free survival, making it impossible to analyze the PFS data. I was utilizing for my control group that IMUC control data.

But my analyses were dead on for overall survival and comparison of external controls. Very positive. Very significant. Approvable.

Very happy to hear the 27 modules are completed or nearly so.

No significant advances have occurred in this disease for many decades. And this treatment has essentially 0 side effects. And one cannot say that for standard treatments.

This will be approved absolutely.

GBM patients have very few other good options for overall quality survival advantage.